These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 17368819)

  • 1. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
    Qiu X; Alimonti JB; Melito PL; Fernando L; Ströher U; Jones SM
    Clin Immunol; 2011 Nov; 141(2):218-27. PubMed ID: 21925951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction and characterization of monoclonal antibodies specific to GP of Ebola virus.
    Tian X; Chen D; Wang H; Xu S; Zhu L; Wu X; Wu Z
    J Med Virol; 2020 Aug; 92(8):996-1006. PubMed ID: 31663613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
    Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
    J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus.
    Zai J; Yi K; Xie L; Zhu J; Feng X; Li Y
    Diagn Pathol; 2018 Dec; 13(1):96. PubMed ID: 30567559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes required for antibody-dependent enhancement of Ebola virus infection.
    Takada A; Ebihara H; Feldmann H; Geisbert TW; Kawaoka Y
    J Infect Dis; 2007 Nov; 196 Suppl 2():S347-56. PubMed ID: 17940970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
    Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
    Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies.
    Hardy ME; Tanaka TN; Kitamoto N; White LJ; Ball JM; Jiang X; Estes MK
    Virology; 1996 Mar; 217(1):252-61. PubMed ID: 8599210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus.
    Berhane Y; Berry JD; Ranadheera C; Marszal P; Nicolas B; Yuan X; Czub M; Weingartl H
    J Virol Methods; 2006 Mar; 132(1-2):59-68. PubMed ID: 16226320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein.
    Chua CL; Chan YF; Sam IC
    J Virol Methods; 2014 Jan; 195():126-33. PubMed ID: 24134938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
    Gelanew T; Poole-Smith BK; Hunsperger E
    J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species.
    Hernandez H; Marceau C; Halliday H; Callison J; Borisevich V; Escaffre O; Creech J; Feldmann H; Rockx B
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S410-3. PubMed ID: 25999057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.